» Articles » PMID: 34901128

Dissolution Study on Grape Polyphenol Hard Gelatin Capsule Dietary Supplements

Overview
Journal Front Nutr
Date 2021 Dec 13
PMID 34901128
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Methods for a dissolution study by ultra-high performance liquid chromatography/triple quadrupole mass spectrometry (UHPLC-QqQ/MS) analysis of grape polyphenol dietary supplements, namely, grape seed extract (GSE) and resveratrol (RSV) capsules, were developed following the guidance of United States Pharmacopeia (USP) <2040>. Two dissolution media, 0.1 N hydrochloric acid (pH 1.2) and 0.05 M acetate buffer (pH 4.6), were evaluated with dissolution apparatus (USP 1), 100 rpm rotation speed, and 900 ml dissolution medium volume. Dissolution profiling was performed over 120 min. Major phenolic compounds of gallic acid, catechin, epicatechin, and procyanidin B2 were quantitated to obtain the dissolution profile of GSE capsules, and trans-RSV was used for RSV capsules. Results indicated that the released trans-RSV for RSV capsules in both of the dissolution media meets the USP standards, and that for the GSE capsules, all the four marker compounds passed the dissolution test in the HCl medium but did not reach a 75% release within 60 min in the acetate buffer. These promising results suggest that the general USP dissolution protocols are adequate for the successful release of RSV capsules in HCl medium and acetate buffer and GSE capsules (in HCl medium), but may be inadequate for GSE capsules in acetate buffer. These results showed that under a low pH of 1.2 (simulated stomach environment), bioactive compounds were released on time from the GSE capsules and met the USP guidelines; however, under a higher pH of 4.6 (simulated duodenum environment), the same biomarkers failed, suggesting the need to further improve the dissolution of GSE over a wider range of pH environments to enhance bioavailability and efficacy.

Citing Articles

Designing an effective dissolution test for bilayer tablets tailored for optimal melatonin release in sleep disorder management.

Bassetto R, Amadio E, Ciampanelli F, Perin S, Ilari P, Gaballo P Front Nutr. 2024; 11:1394330.

PMID: 38769992 PMC: 11102985. DOI: 10.3389/fnut.2024.1394330.


Dietary Supplements with Proline-A Comprehensive Assessment of Their Quality.

Stepien K, Krawczyk W, Giebultowicz J Life (Basel). 2023; 13(2).

PMID: 36836622 PMC: 9958592. DOI: 10.3390/life13020263.


3--Ethyl-L-Ascorbic Acid Doped Enteric-Coated Gelatin Capsules towards the Advanced Oral Curcumin Delivery for Cancers.

Lim D Polymers (Basel). 2022; 14(11).

PMID: 35683880 PMC: 9182627. DOI: 10.3390/polym14112207.


Application of Liquid Chromatography Coupled to Mass Spectrometry in Quality Assessment of Dietary Supplements-A Case Study of Tryptophan Supplements: Release Assay, Targeted and Untargeted Studies.

Stepien K, Giebultowicz J Pharmaceuticals (Basel). 2022; 15(4).

PMID: 35455446 PMC: 9031539. DOI: 10.3390/ph15040448.


Chemical, Manufacturing, and Standardization Controls of Grape Polyphenol Dietary Supplements in Support of a Clinical Study: Mass Uniformity, Polyphenol Dosage, and Profiles.

Lyu W, Rodriguez D, Ferruzzi M, Pasinetti G, Murrough J, Simon J Front Nutr. 2022; 8:780226.

PMID: 34977124 PMC: 8716858. DOI: 10.3389/fnut.2021.780226.

References
1.
Basly J, Le Bail J, Habrioux G, Chulia A . Estrogenic/antiestrogenic and scavenging properties of (E)- and (Z)-resveratrol. Life Sci. 2000; 66(9):769-77. DOI: 10.1016/s0024-3205(99)00650-5. View

2.
Chen X, He H, Wang G, Yang B, Ren W, Ma L . Stereospecific determination of cis- and trans-resveratrol in rat plasma by HPLC: application to pharmacokinetic studies. Biomed Chromatogr. 2007; 21(3):257-65. DOI: 10.1002/bmc.747. View

3.
Delmas D, Aires V, Limagne E, Dutartre P, Mazue F, Ghiringhelli F . Transport, stability, and biological activity of resveratrol. Ann N Y Acad Sci. 2011; 1215:48-59. DOI: 10.1111/j.1749-6632.2010.05871.x. View

4.
Wang J, Ferruzzi M, Ho L, Blount J, Janle E, Gong B . Brain-targeted proanthocyanidin metabolites for Alzheimer's disease treatment. J Neurosci. 2012; 32(15):5144-50. PMC: 3348654. DOI: 10.1523/JNEUROSCI.6437-11.2012. View

5.
Perez-Jimenez J, Saura-Calixto F . Grape products and cardiovascular disease risk factors. Nutr Res Rev. 2008; 21(2):158-73. DOI: 10.1017/S0954422408125124. View